HIMS

Being a leading telehealth company in the US could be a 10x, maybe even a bigger opportunity for Hims & Hers, but beating being the global telehealth company where you go to answer all your questions no matter where you are in the world is really where the massive opportunity is for healthcare and for Hims & Hers.

Number one, we're going to discuss Hims stock in this video, okay? There was some news that came out in regards to Hims. Stock went down heavy. I want to talk about that.

Hims stock got hammered here today, down 8% roughly, right? Tough day for Hims stock. Of the stocks on my watchlist, you know, 4000xstocks.com, that was the worst performer here today.

Hims & Hers, as for everything that it has gone through this year, is actually still down almost 20% for the year, but you can see shares bottomed in late February. Since then, up nearly 100% pulled back just a little bit.

They were trading at nearly $40 per share in early July. So, since then, down about 25%. Very volatile stock. So, something to keep in mind for investors.